Researchers harness cancer cells’ carbon monoxide to produce anticancer drug
What if we could use a cancer’s own byproduct to make drugs that destroy tumor cells from the…
RNA modification enzyme FTO shows therapeutic promise in gastrointestinal cancers
A new review in Genes & Diseases highlights FTO, an enzyme involved in RNA modification, as a potentially…
Late-Night Snacking Linked to Higher Risk of Liver Disease
Researchers from Oregon Health & Science University and Massachusetts General Hospital have found that people who reported eating…
Study finds both the liver and brain drive distinct symptoms of rare genetic epilepsy
A recent study from Johns Hopkins Medicine reveals that both the liver and brain contribute pathways to differing…
Why is dengue spreading while malaria has declined?
As rising temperatures reshape mosquito-borne disease risks worldwide, researchers reveal why dengue is expanding while malaria has historically…
Experimental mRNA therapy protects the liver after acetaminophen overdose
When a patient arrives at the hospital with an acetaminophen overdose, it’s often a race against the clock.…
UCLA researchers present new radiation advances at ASTRO 2026
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share new research and clinical trial…
Advances in chemistry and delivery are taking oligonucleotide medicines beyond rare diseases
Decades of work on RNA targeting, chemical modification, and tissue-specific delivery are reshaping what programmable genetic medicines can…
Siemens Healthineers and Novo join forces to advance care for people living with MASLD and MASH
Siemens Healthineers and Novo have announced a collaboration focused on advancing care for people living with metabolic dysfunction-associated…
Study defines early-onset cirrhosis caused by fatty liver disease
Researchers at University of California San Diego School of Medicine have published the first study to define early-onset…
How a 43-Year-Old Man With Colon Cancer Uses AI to Manage His Symptoms
Russ Read-Barrow has been living with incurable stage four colon cancer for five years. The 43-year-old former PR…
Could scorpion venom inspire new treatments for liver disease?
From blocking inflammatory immune pathways to disrupting hepatitis viruses, scorpion-derived peptides are attracting attention as potential drug candidates,…